ClinicalTrials.gg
Active, not recruitingNCT04641026Updated Aug 7, 2026

Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Serving)

An interventional study of Broccoli sprouts and Deuterium oxide-labelled broccoli sprouts in Diet, Healthy, sponsored by Oregon State University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by Oregon State University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
83
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The purpose of this project is to study the molecular and metabolic profiles in human plasma, urine and microbiome composition following the consumption of broccoli sprouts.

Read the detailed description

The investigators wish to examine metabolic and molecular markers found in blood and in urine after a single dose of sprouts, and evaluate the importance of the gut microbiome on these parameters. Some subjects will receive broccoli sprouts that are grown in deuterium oxide, a commonly used non-toxic, non-radioactive label for vegetables (Tang, Qin et al. 2005), so researchers can identify metabolites in blood and urine that are directly from consumed sprouts. The investigators plan to feed subjects a standardized breakfast and either broccoli sprouts or alfalfa sprouts (control) and look at the presence of metabolites and activity in the blood and urine 3, 6, 24, 48 and 72 hours following intake as well as changes in microbiome composition.

02

Conditions studied

  • Diet, Healthy

Keywords

  • broccoli sprout
  • microbiome
  • cruciferous vegetable
03

In context

Lead sponsor

Oregon State University is the lead sponsor of 38 studies on the registry; 2 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 4 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy men and women, 18-60 years of age
  • Willing to stop taking herbal and phytochemical (plant-based extract or phytochemical) supplements for 1 week prior to and during the study
  • Willing to stop cruciferous vegetable and probiotic supplement, food and beverage intake 1 week prior to and during the study
  • Willing to complete a 10-day food diary during the study
  • Must be able to give written

Exclusion criteria

Exclusion Criteria:

  • (BMI) \<18.5 or >30.0 kg/m2
  • Tobacco use, including e-cigarettes, or smoking of any substance (e.g. cannabis) in the past three months
  • Pregnancy, breastfeeding, or planning to become pregnant before completing the study
  • Engaging in vigorous exercise more than 7 hours per week
  • Have a significant acute or chronic illness such as cardiovascular disease, kidney or liver disease, diabetes, thyroid disorder, or radiation or chemotherapy treatment for cancer within the past five years.
  • Use of medications to control cholesterol (e.g. statins, cholestyramine) or fat absorption (e.g. orlistat)
  • Have had bariatric surgery (e.g. gastric bypass, gastric banding, sleeve gastrectomy, etc.), other gastrointestinal procedure (e.g. cholecystectomy) or disorders (e.g. Crohn's disease, celiac disease, ulcerative colitis)
  • Use of oral antibiotic medication within the 6 months
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
83 participants (actual)

Study arms

  • Active comparator
    Broccoli sprouts

    Subjects will consume one serving (about 1 cup) of broccoli sprouts with breakfast (bagel, cream cheese, and orange juice).

    Other: Broccoli sprouts

  • Active comparator
    Deuterium oxide-labeled broccoli sprouts

    Subjects will consume one serving (about 1 cup) of deuterium oxide-labeled broccoli sprouts with breakfast (bagel, cream cheese, and orange juice).

    Other: Deuterium oxide-labelled broccoli sprouts

  • Placebo comparator
    Alfalfa sprouts

    Subjects will consume one serving (about 1 cup) of alfalfa sprouts with breakfast (bagel, cream cheese, and orange juice).

    Other: Alfalfa sprouts

  • Placebo comparator
    Deuterium oxide-labeled alfalfa sprouts

    Subjects will consume one serving (about 1 cup) of deuterium oxide-labeled alfalfa sprouts with breakfast (bagel, cream cheese, and orange juice).

    Other: Deuterium oxide-labelled alfalfa sprouts

Interventions

  • OtherBroccoli sprouts

    Subjects will consume one serving (about 1 cup) of broccoli sprouts with breakfast (bagel, cream cheese, and orange juice).

  • OtherDeuterium oxide-labelled broccoli sprouts

    Subjects will consume one serving (about 1 cup) of deuterium oxide-labelled broccoli sprouts with breakfast (bagel, cream cheese, and orange juice).

  • OtherAlfalfa sprouts

    Subjects will consume one serving (about 1 cup) of alfalfa sprouts with breakfast (bagel, cream cheese, and orange juice).

  • OtherDeuterium oxide-labelled alfalfa sprouts

    Subjects will consume one serving (about 1 cup) of deuterium oxide-labelled alfalfa sprouts with breakfast (bagel, cream cheese, and orange juice).

06

What researchers measure

Primary outcomes

  1. Urine sulforaphane

    Change in levels of sulforaphane metabolites in urine

    Time frame: Baseline, 3, 6, 24, 48 and 72 hours after consuming a single serving of sprouts

  2. Urine sulforaphane metabolites

    Change in levels of sulforaphane metabolites in urine

    Time frame: Baseline, 3, 6, 24, 48 and 72 hours after consuming a single serving of sprouts

  3. Plasma sulforaphane

    Change in levels of sulforaphane in plasma

    Time frame: Baseline, 3, 6, 24, 48 and 72 hours after consuming a single serving of sprouts

  4. Plasma sulforaphane metabolites

    Change in levels of sulforaphane metabolites in plasma

    Time frame: Baseline, 3, 6, 24, 48 and 72 hours after consuming a single serving of sprouts

  5. Stool sample based gut microbiome composition using 16S rRNA gene sequencing

    Change in stool sample based gut microbiome composition using 16S rRNA gene sequencing

    Time frame: Baseline, 3, 6, 24, 48 and 72 hours after consuming a single serving of sprouts

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2021 to primary completion in Dec 2025, 57 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 29, 2020
First posted
Nov 23, 2020
StartActual
Feb 22, 2021
Primary completionActual
Dec 15, 2025
CompletionEst.
Dec 2027
Last update
Aug 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04641026
Lead sponsor
Oregon State University
Collaborators
United States Department of Agriculture (USDA)
Responsible party
Emily Ho (Endowed Chair and Director, Linus Pauling Institute Professor, College of Public Health and Human Sciences, Oregon State University) — Principal investigator
First posted
Nov 23, 2020
Start date
Feb 22, 2021
Primary completion
Dec 15, 2025
Completion
Dec 2027 (estimated)
Last update
Aug 7, 2026

Study contacts

Emily Ho, PhD
principal investigator · Oregon State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion